Warning: The NCBI web site requires JavaScript to function. more...
Inhibition of macropinocytosis blocks antigen presentation of type II collagen in vitro and in vivo in HLA-DR1 transgenic mice.
von Delwig A, Hilkens CM, Altmann DM, Holmdahl R, Isaacs JD, Harding CV, Robertson H, McKie N, Robinson JH.
Arthritis Res Ther. 2006;8(4):R93.
Related citations
The impact of glycosylation on HLA-DR1-restricted T cell recognition of type II collagen in a mouse model.
von Delwig A, Altmann DM, Isaacs JD, Harding CV, Holmdahl R, McKie N, Robinson JH.
Arthritis Rheum. 2006 Feb;54(2):482-91.
Ex vivo characterization of the autoimmune T cell response in the HLA-DR1 mouse model of collagen-induced arthritis reveals long-term activation of type II collagen-specific cells and their presence in arthritic joints.
Latham KA, Whittington KB, Zhou R, Qian Z, Rosloniec EF.
J Immunol. 2005 Apr 1;174(7):3978-85.
T cell receptors recognizing type II collagen in HLA-DR-transgenic mice characterized by highly restricted V beta usage.
He X, Rosloniec EF, Myers LK, McColgan WL 3rd, Gumanovskaya M, Kang AH, Stuart JM.
Arthritis Rheum. 2004 Jun;50(6):1996-2004.
Collagen-induced arthritis mediated by HLA-DR1 (*0101) and HLA-DR4 (*0401).
Rosloniec EF, Whittington KB, He X, Stuart JM, Kang AH.
Am J Med Sci. 2004 Apr;327(4):169-79.
Peptide-induced suppression of collagen-induced arthritis in HLA-DR1 transgenic mice.
Myers LK, Sakurai Y, Tang B, He X, Rosloniec EF, Stuart JM, Kang AH.
Arthritis Rheum. 2002 Dec;46(12):3369-77.
HLA-DR1 (DRB1*0101) and DR4 (DRB1*0401) use the same anchor residues for binding an immunodominant peptide derived from human type II collagen.
Rosloniec EF, Whittington KB, Zaller DM, Kang AH.
J Immunol. 2002 Jan 1;168(1):253-9.
Differential MHC class II-mediated presentation of rheumatoid arthritis autoantigens by human dendritic cells and macrophages.
Tsark EC, Wang W, Teng YC, Arkfeld D, Dodge GR, Kovats S.
J Immunol. 2002 Dec 1;169(11):6625-33.
HLA-DM negatively regulates HLA-DR4-restricted collagen pathogenic peptide presentation and T cell recognition.
Amria S, Hajiaghamohseni LM, Harbeson C, Zhao D, Goldstein O, Blum JS, Haque A.
Eur J Immunol. 2008 Jul;38(7):1961-70.
Tracking of proinflammatory collagen-specific T cells in early and late collagen-induced arthritis in humanized mice.
Svendsen P, Andersen CB, Willcox N, Coyle AJ, Holmdahl R, Kamradt T, Fugger L.
J Immunol. 2004 Dec 1;173(11):7037-45.
Analog peptides of type II collagen can suppress arthritis in HLA-DR4 (DRB1*0401) transgenic mice.
Sakurai Y, Brand DD, Tang B, Rosloniec EF, Stuart JM, Kang AH, Myers LK.
Arthritis Res Ther. 2006;8(5):R150.
An analog peptide that suppresses collagen-induced arthritis.
Myers LK, Sakurai Y, Rosloniec EF, Stuart JM, Kang AH.
Am J Med Sci. 2004 Apr;327(4):212-6.
Presentation of arthritogenic peptide to antigen-specific T cells by fibroblast-like synoviocytes.
Tran CN, Davis MJ, Tesmer LA, Endres JL, Motyl CD, Smuda C, Somers EC, Chung KC, Urquhart AG, Lundy SK, Kovats S, Fox DA.
Arthritis Rheum. 2007 May;56(5):1497-506.
An autoantigen-specific, highly restricted T cell repertoire infiltrates the arthritic joints of mice in an HLA-DR1 humanized mouse model of autoimmune arthritis.
Qian Z, Latham KA, Whittington KB, Miller DC, Brand DD, Rosloniec EF.
J Immunol. 2010 Jul 1;185(1):110-8. Epub 2010 May 28.
Depletion of collagen II-reactive T cells and blocking of B cell activation prevents collagen II-induced arthritis in DBA/1j mice.
Zhang HG, Yang P, Xie J, Liu Z, Liu D, Xiu L, Zhou T, Wang Y, Hsu HC, Mountz JD.
J Immunol. 2002 Apr 15;168(8):4164-72.
T cell immunity to type II collagen in the biobreeding rat: the identification and characterization of RT1u-restricted T cell epitopes on alpha 1(II).
Cremer MA, Ye XJ, Myers LK, Brand DD, Rosloniec EF, Kang AH.
J Immunol. 2004 Aug 1;173(3):1795-801.
An HLA-DR1 transgene confers susceptibility to collagen-induced arthritis elicited with human type II collagen.
Rosloniec EF, Brand DD, Myers LK, Whittington KB, Gumanovskaya M, Zaller DM, Woods A, Altmann DM, Stuart JM, Kang AH.
J Exp Med. 1997 Mar 17;185(6):1113-22.
Efficacy of modified recombinant type II collagen in modulating autoimmune arthritis.
Myers LK, Tang B, Brand DD, Rosloniec EF, Stuart JM, Kang AH.
Arthritis Rheum. 2004 Sep;50(9):3004-11.
Cysteine proteases in Langerhans cells limits presentation of cartilage derived type II collagen for autoreactive T cells.
Holmdahl M, Grubb A, Holmdahl R.
Int Immunol. 2004 May;16(5):717-26. Epub 2004 Apr 13.
[The inhibitory effect of hyporesponsive peptide on human leukocyte antigen-DRbeta1 specific T cell activation].
Zhou Q, Cheng YJ, Li ZG, Zhou WH, Lu HS.
Zhonghua Yi Xue Za Zhi. 2003 Sep 10;83(17):1505-9. Chinese.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on